Actinium Pharmaceuticals Inc (AMEX:ATNM)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 0.13. At the close of trading, the stock’s price was $6.85, to imply an increase of 2.70% or $0.18 in intraday trading. The ATNM share’s 52-week high remains $9.86, putting it -43.94% down since that peak but still an impressive 41.61% since price per share fell to its 52-week low of $4.00. The company has a valuation of $201.39M, with an average of 356.22K shares over the past 3 months.

Actinium Pharmaceuticals Inc (AMEX:ATNM) trade information

After registering a 2.70% upside in the last session, Actinium Pharmaceuticals Inc (ATNM) has traded red over the past five days. The stock hit a weekly high of 9.10, jumping 2.70% in its intraday price action. The 5-day price performance for the stock is -23.89%, and -20.35% over 30 days. With these gigs, the year-to-date price performance is 34.84%.

Actinium Pharmaceuticals Inc (ATNM) estimates and forecasts

Looking at statistics comparing Actinium Pharmaceuticals Inc share performance against respective industry, we note that the company has underperformed competitors. Actinium Pharmaceuticals Inc (ATNM) shares are 17.29% up over the last 6 months, with its year-to-date growth rate lower than industry average at -2.19% against 10.20%.

ATNM Dividends

Actinium Pharmaceuticals Inc has its next earnings report out between May 15 and May 30. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Actinium Pharmaceuticals Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.